Radiopaque enhanced cobalt alloy for stents

US9592135B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9592135-B2
Application numberUS-201313771907-A
CountryUS
Kind codeB2
Filing dateFeb 20, 2013
Priority dateApr 26, 2012
Publication dateMar 14, 2017
Grant dateMar 14, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A stent is formed of at least a cobalt-based alloy. The cobalt-based alloy may include 10-35 weight % metal member selected from the group consisting of platinum (Pt), gold (Au), iridium (Ir), osmium (Os), rhenium (Re), tungsten (W), palladium (Pd), tantalum (Ta), and combinations thereof; 16-21 weight % chromium (Cr); 9-12 weight % molybdenum (Mo); 0-25 weight % nickel (Ni); and balance cobalt (Co). The cobalt-based alloy may be a thin outer shell of a hollow stent. The cobalt-based alloy may be used to form at least one of an inner core and an outer shell of a core-shell structure of a stent. The cobalt-based alloy may be used to form an end of a wire for forming a stent.

First claim

Opening claim text (preview).

What is claimed is: 1. A medical device comprising: a cobalt-based alloy comprising 10-35 weight % material selected from the group consisting of platinum (Pt), gold (Au), iridium (Ir), osmium (Os), rhenium (Re), tungsten (W), palladium (Pd), tantalum (Ta), and combinations thereof; 16-21 weight % chromium (Cr); 9-12 weight % molybdenum (Mo); 3-25 weight % nickel (Ni); and balance cobalt (Co). 2. The medical device of claim 1 , wherein the cobalt-based alloy further comprises one or more of 0-3 weight % iron (Fe); 0-0.015 weight % boron (B); 0-0.15 weight % carbon (C); 0-1.5 weight % manganese (Mn); 0-0.04 weight % phosphorous (P); 0-1.0 weight % silicon (Si); 0-1 weight % titanium (Ti); and 0-0.03 weight % sulfur (S). 3. The medical device of claim 1 , wherein the cobalt-based alloy further comprises one or more of about 0.010 weight % boron (B); 0-0.025 weight % carbon (C); 0-1.0 weight % iron (Fe); 0-0.15 weight % manganese (Mn); 0-0.015 weight % phosphorous (P); 0-0.15 weight % silicon (Si); 0-0.01 weight % sulfur (S); and 0-1 weight % titanium (Ti). 4. The medical device of claim 1 , wherein the cobalt-based alloy is formed of about 24 weight % platinum (Pt); about 20 weight % chromium (Cr); about 10 weight % molybdenum (Mo); about 15 weight % nickel (Ni); and balance cobalt (Co). 5. The medical device of claim 1 , wherein the cobalt-based alloy is formed of about 20.1 weight % platinum (Pt); about 16.8 weight % chromium (Cr); about 11.1 weight % molybdenum (Mo); about 17.2 weight % nickel (Ni); and balance cobalt (Co). 6. The medical device of claim 1 , wherein the cobalt-based alloy is formed of about 0.015 weight % boron (B); about 0.025 weight % carbon (C); about 20 weight % chromium (Cr); about 1 weight % iron (Fe); about 0.15 weight % manganese (Mn); about 10 weight % molybdenum (Mo); about 12 weight % nickel (Ni); about 0.015 weight % phosphorous (P); about 24 weight % platinum (Pt); about 0.15 weight % silicon (Si); about 0.01 weight % sulfur (S); about 0.01 weight % titanium (Ti); and balance cobalt (Co). 7. The medical device of claim 1 , wherein the cobalt-based alloy forms at least one strut of the stent. 8. The medical device of claim 1 , wherein the stent comprises a core-shell structure having an outer shell substantially surrounding an inner core, and wherein one or more of the outer shell and the inner core is formed of the cobalt-based alloy. 9. The medical device of claim 1 , wherein the stent comprises a core-shell structure having an outer shell substantially surrounding an inner core, wherein one of the outer shell and the inner core is formed of the cobalt-based alloy and the other thereof is formed of a metal member. 10. The medical device of claim 9 , wherein the metal member is a metal selected from the group consisting of platinum (Pt), gold (Au), iridium (Ir), osmium (Os), rhenium (Re), tungsten (W), palladium (Pd), tantalum (Ta), and combinations thereof. 11. The medical device of claim 1 , wherein the stent comprises a core-shell structure having an outer shell substantially surrounding an inner core, and wherein the inner core is hollow and the outer shell is formed of the cobalt-based alloy having a thickness of about 0.0010 inches or less. 12. The medical device of claim 1 , wherein the stent comprises a core-shell structure having an outer shell substantially surrounding an inner core comprising Ta, wherein the outer shell comprises the cobalt-based alloy formed of about 24 weight % platinum (Pt); about 20 weight % chromium (Cr); about 10 weight % molybdenum (Mo); about 12 weight % nickel (Ni); and balance cobalt (Co). 13. The medical device of claim 1 , wherein the stent comprises a core-shell structure having an outer shell substantially surrounding an inner core comprising Ta, wherein the outer shell comprises the cobalt-based alloy formed of about 19.5 weight % platinum (Pt); about 19 weight % chromium (Cr); about 11 weight % molybdenum (Mo); about 17 weight % nickel (Ni); and balance cobalt (Co). 14. A medical device comprising: a cobalt-based alloy comprising 10-35 weight % material selected from the group consisting of platinum (Pt), gold (Au), iridium (Ir), osmium (Os), rhenium (Re), tungsten (W), palladium (Pd), tantalum (Ta), and combinations thereof; about 24 weight % platinum (Pt); about 20 weight % chromium (Cr); about 10 weight % molybdenum (Mo); about 15 weight % nickel (Ni); and balance cobalt (Co). 15. A medical device comprising: a cobalt-based alloy comprising 10-35 weight % material selected from the group consisting of platinum (Pt), gold (Au), iridium (Ir), osmium (Os), rhenium (Re), tungsten (W), palladium (Pd), tantalum (Ta), and combinations thereof; about 20.1 weight % platinum (Pt); about 16.8 weight % chromium (Cr); about 11.1 weight % molybdenum (Mo); about 17.2 weight % nickel (Ni); and balance cobalt (Co). 16. A medical device comprises a core-shell structure having an outer shell substantially surrounding an inner core comprising Ta, wherein the outer shell comprises a cobalt-based alloy comprising 10-35 weight % material selected from the group consisting of platinum (Pt), gold (Au), iridium (Ir), osmium (Os), rhenium (Re), tungsten (W), palladium (Pd), tantalum (Ta), and combinations thereof; about 19.5 weight % platinum (Pt); about 19 weight % chromium (Cr); about 11 weight % molybdenum (Mo); about 17 weight % nickel (Ni); and balance cobalt (Co). 17. A medical device comprising: a cobalt-based alloy comprising 10-35 weight % material selected from the group consisting of platinum (Pt), gold (Au), iridium (Ir), osmium (Os), rhenium (Re), tungsten (W), palladium (Pd), tantalum (Ta), and combinations thereof; about 0.015 weight % boron (B); about 0.025 weight % carbon (C); about 20 weight % chromium (Cr); about 1 weight % iron (Fe); about 0.15 weight % manganese (Mn); about 10 weight % molybdenum (Mo); about 12 weight % nickel (Ni); about 0.015 weight % phosphorous (P); about 24 weight % platinum (Pt); about 0.15 weight % silicon (Si); about 0.01 weight % sulfur (S); about 0.01 weight % titanium (Ti); and balance cobalt (Co). 18. A medical device comprises a core-shell structure having an outer shell substantially surrounding an inner core comprising Ta, wherein the outer shell comprises a cobalt-based alloy comprising 10-35 weight % material selected from the group consisting of platinum (Pt), gold (Au), iridium (Ir), osmium (Os), rhenium (Re), tungsten (W), palladium (Pd), tantalum (Ta), and combinations thereof; about 24 weight % platinum (Pt); about 20 weight % chromium (Cr); about 10 weight % molybdenum (Mo); about 12 weight % nickel (Ni); and balance cobalt (Co).

Assignees

Inventors

Classifications

  • A61F2/82Primary

    Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents (stent-grafts for tubular structures of the body other than blood vessels A61F2/04; stent-grafts for blood vessels A61F2/07) · CPC title

  • radio-opaque, e.g. radio-opaque markers · CPC title

  • based on cobalt · CPC title

  • A61L31/022Primary

    Metals or alloys · CPC title

  • A61F2/915Primary

    with bands having a meander structure, adjacent bands being connected to each other · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9592135B2 cover?
A stent is formed of at least a cobalt-based alloy. The cobalt-based alloy may include 10-35 weight % metal member selected from the group consisting of platinum (Pt), gold (Au), iridium (Ir), osmium (Os), rhenium (Re), tungsten (W), palladium (Pd), tantalum (Ta), and combinations thereof; 16-21 weight % chromium (Cr); 9-12 weight % molybdenum (Mo); 0-25 weight % nickel (Ni); and balance cobalt…
Who is the assignee on this patent?
Medtronic Vascular Inc
What technology area does this patent fall under?
Primary CPC classification A61F2/82. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).